Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with a $175 million SEC-registered common stock and pre-funded warrants…
Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Uber Technologies, Inc. of $1.15 billion aggregate principal amount of its 0% convertible senior notes…
Davis Polk advised the sales agents on the SEC-registered at-the-market offering by RAPT Therapeutics, Inc. of its common stock for up to an aggregate amount of $100 million.
RAPT…
Davis Polk advised the sales agent on the SEC-registered at-the-market offering by Revance Therapeutics, Inc. of its common stock for up to an aggregate amount of $125 million.
Based…